ArticleCancer chemotherapy and pharmacology2017

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition.

Gayathri Srinivasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.